NO880267L - 11beta-alkynyl-oestren og -oestradiener, fremstilling av disse og farmastoeytiske preparater inneholdende disse. - Google Patents

11beta-alkynyl-oestren og -oestradiener, fremstilling av disse og farmastoeytiske preparater inneholdende disse.

Info

Publication number
NO880267L
NO880267L NO880267A NO880267A NO880267L NO 880267 L NO880267 L NO 880267L NO 880267 A NO880267 A NO 880267A NO 880267 A NO880267 A NO 880267A NO 880267 L NO880267 L NO 880267L
Authority
NO
Norway
Prior art keywords
eastern
phenyl
alkyl
optionally substituted
11beta
Prior art date
Application number
NO880267A
Other languages
English (en)
Other versions
NO880267D0 (no
NO169344C (no
NO169344B (no
Inventor
Eckhard Ottow
Rudolf Wiechert
Guenter Neef
Juergen Bardenhagen
Sybille Beier
Walter Elger
David Henderson
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO880267D0 publication Critical patent/NO880267D0/no
Publication of NO880267L publication Critical patent/NO880267L/no
Priority to NO883869A priority Critical patent/NO169345C/no
Publication of NO169344B publication Critical patent/NO169344B/no
Publication of NO169344C publication Critical patent/NO169344C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
NO880267A 1987-01-23 1988-01-22 11beta-substituerte steroider og antikonsepsjonsmidler inneholdende disse NO169344C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO883869A NO169345C (no) 1987-01-23 1988-08-30 Analogifremgansmaate for fremstilling av terapeutisk aktive 11beta-substituerte steroider

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873702383 DE3702383A1 (de) 1987-01-23 1987-01-23 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate

Publications (4)

Publication Number Publication Date
NO880267D0 NO880267D0 (no) 1988-01-22
NO880267L true NO880267L (no) 1988-07-25
NO169344B NO169344B (no) 1992-03-02
NO169344C NO169344C (no) 1992-06-10

Family

ID=6319636

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880267A NO169344C (no) 1987-01-23 1988-01-22 11beta-substituerte steroider og antikonsepsjonsmidler inneholdende disse

Country Status (15)

Country Link
US (1) US4870069A (no)
EP (1) EP0277089B1 (no)
JP (1) JPS63201197A (no)
AT (1) ATE64399T1 (no)
AU (1) AU616395B2 (no)
CA (1) CA1326014C (no)
DE (2) DE3702383A1 (no)
DK (1) DK2088A (no)
ES (1) ES2038783T3 (no)
GR (1) GR3002110T3 (no)
IE (1) IE60321B1 (no)
NO (1) NO169344C (no)
NZ (1) NZ223269A (no)
PT (1) PT86591B (no)
ZA (1) ZA88464B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3633244A1 (de) * 1986-09-26 1988-03-31 Schering Ag Antigestagene zur hemmung der uterinen prostaglandinsynthese
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
DE4042007A1 (de) * 1990-12-22 1992-06-25 Schering Ag 6,7-modifizierte-11(beta)-aryl-4-estrene
EP0496520A1 (en) * 1991-01-22 1992-07-29 Merck & Co. Inc. Novel bone acting agents
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
CA2100514C (en) * 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
US6037339A (en) 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
US5710144A (en) * 1993-02-08 1998-01-20 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6090798A (en) * 1997-12-19 2000-07-18 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with glucocorticoid antagonists
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
DE102007063499A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft Steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063496A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063498A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063500A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-(1'-Propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236866A (en) * 1959-04-08 1966-02-22 Syntex Corp 21, 21-difluoro pregnenes
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene

Also Published As

Publication number Publication date
JPS63201197A (ja) 1988-08-19
IE60321B1 (en) 1994-06-29
DE3702383A1 (de) 1988-08-04
ES2038783T3 (es) 1993-08-01
EP0277089B1 (de) 1991-06-12
DE3863182D1 (de) 1991-07-18
ZA88464B (en) 1988-09-28
GR3002110T3 (en) 1992-12-30
PT86591B (pt) 1991-12-31
NO880267D0 (no) 1988-01-22
AU616395B2 (en) 1991-10-31
PT86591A (pt) 1988-02-01
DK2088D0 (da) 1988-01-05
ATE64399T1 (de) 1991-06-15
IE880171L (en) 1988-07-23
US4870069A (en) 1989-09-26
NO169344C (no) 1992-06-10
DK2088A (da) 1988-07-24
AU1111488A (en) 1988-07-28
CA1326014C (en) 1994-01-11
NZ223269A (en) 1990-09-26
EP0277089A1 (de) 1988-08-03
NO169344B (no) 1992-03-02

Similar Documents

Publication Publication Date Title
NO880267L (no) 11beta-alkynyl-oestren og -oestradiener, fremstilling av disse og farmastoeytiske preparater inneholdende disse.
FI20040479A (fi) 3-aminopiperidiinijohdannaisia ja menetelmiä niiden valmistamiseksi
AP9801274A0 (en) Lactone derivatives of 17, beta.carboxy, carbothio and amide androstane derivatives.
ATE116310T1 (de) Benzo(5,6)cycloheptapyridine, zusammensetzungen und verwendung.
ES2052704T3 (es) Analogos de benzodiacepina.
NO875440D0 (no) Fremgangsmaate for fremstilling av kalsiumuavhengig camp-fosfodiesterase-inhibitorantidepressivt middel.
DE69108138D1 (de) Imidazopyridinderivate und ihre Verwendung.
DK57492D0 (da) Farmaceutiske praeparater af n-phenylbenzamidderivater
FI925988A (fi) Foerfarande foer framstaellning av b-laktamer
NO913176D0 (no) Morfolinylderivater av doxorubicin og deres fremstilling.
PH30831A (en) Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia.
HU891441D0 (en) Process for the preparation of novel 1,4-benzoxazine and 1,4-benzothiazine derivatives
ES8704919A1 (es) Procedimiento para preparar derivados de (+)-cianidan-3-ol
EP0253468A3 (en) Six-membered heterocyclic derivatives of n'substituted-n,n'-diacylhydrazines
DK301689A (da) 4,5,7,8-tetrahydro-6h-thiazolooe5,4-daaazepiner samt laegemidler med indhold af saadenne forbindelser
EP0272174A3 (fr) Préparations d'adenyl cyclase purifiées, procédé d'obtention de ces préparations et leurs applications biologiques
FI894812A0 (fi) Menetelmä valmistaa farmakologisesti arvokkaita 2-karbonyylisubstituoituja N,N'-di(trimetoksibentsoyyli)piperatsiineja
EP0295350A3 (en) Use of n-û2-(diethylamino)ethyl¨-2-methoxy-4-û(1-h 4,5-dihydro-2-imidazolyl)amino¨-5-chlorobenzamide as an anxiolytic and antipsychotic agent
DK473286A (da) Konjugater af vinblastin og derivater deraf, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem
ZA853017B (en) Antibacterial compounds
ATE88464T1 (de) Hydrazin-derivate.
HU0000186D0 (en) New pharmaceutical use of dihydropyridine derivatives condensed with carbocyclic or heterocyclic ring